]>
IRCT2017091335460N1 IRCT 2017-09-13 Vice Chancellor for Research, Kermanshah University of Medical Sciences Evaluation of the efficacy of rectal preparation from Hemoheal® Cream in patients with Hemorrhoid Evaluation of the efficacy of rectal preparation from Hemoheal® Cream on number of excretion daily and rate of rectal bleeding in patients with Hemorrhoid 2017-10-12 anticipated 40 Complete https://irct.ir/trial/26791 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization is performed using blocking method, Blinding description: Blinding is done for patients and physician who measure the outcome of the study. N/A Hemorrohiod. Intervention 1: Intervention: Topical use of thin-layer Hemoheal cream twice a day for a month. Intervention 2: Control: Topical use of thin-layer eucerin base cream twice a day for a month. Undecided - It is not yet known if there will be a plan to make this available
public Fateme Parvizi
Kermanshah University of Medical Sciences, Daneshgah St., Sorkheligheh, Kermanshah
Kermanshah Iran (Islamic Republic of) 6714694451 +98 833429920 parvizi_70@yahoo.com Kermanshah University of Medical Sciences scientific Dr. Mohammad Hosein Farzaei
Kermanshah University of Medical Sciences, Faculty of pharmacy, Daneshgah Ave., Shahid Shiroodi Blv., Kermanshah
Kermanshah Iran (Islamic Republic of) 6734667149 +98 83 3426 6780 mh-farzaee@razi.tums.ac.ir Kermanshah University of Medical Sciences Iran (Islamic Republic of) Age>18 Patients who sign the testimonials and cooperate during the study Patients who their diseases are confirmed by complete medical evaluation including colonoscopy, pathology and laboratory data Only patients with mild to moderate hemorrhoids can be included in this study Patients who were not cured with Hemoheal cream during the last month 18 years no limit Both 4th-degree hemorrhoids Pregnant patients and nursing mothers Patients who have to use other drugs that interference with this medication Previous history of anorectal surgery Patients who are suffering from other diseases in addition to hemorrhoids, such as apparent coagulation abnormalities or kidney impairment accompanied with colorectal diseases such as cancer, Crohn's disease, ulcerative colitis, anal fistula, anal fissure, proctitis or perineal skin inflammation Patients who are disposed to a serious health danger, such as severe cardiac, liver or renal diseases If significant side effects occur, the patient will be excluded from the study and followed to end of the study Patients with severe allergy to this plant (dermatitis contact) I84.8 Unspecified haemorrhoids with other complications Treatment - Drugs Placebo Intervention: Topical use of thin-layer Hemoheal cream twice a day for a month Control: Topical use of thin-layer eucerin base cream twice a day for a month Number of excretion daily. Timepoint: Before using the drug; 2 weeks after using the drug-30 days after using the drugs. Method of measurement: Based on Hemorrohiod clinic questionary. Rate of rectal bleeding. Timepoint: before using the drug; 2 weeks after using the drug-30 days after using the drugs. Method of measurement: based on Hemorrohiod clinic score. Gastrointestinal disorders. Timepoint: Two weeks after using the drug; 30 days after using the drug. Method of measurement: Based on side effect questionary. Vice Chancellor for Research, Kermanshah University of Medical Sciences Approved 2017-10-25 Ethics committee of Kermanshah University of Medical Sciences Kermanshah University of Medical Sciences kermanshah Kermanshah Iran (Islamic Republic of)